Evidence map›Paper›PMID 24413751›Full record

ArticleInternational journal of molecular sciences2014

Increased preventive effect on colon carcinogenesis by use of resistant starch (RS3) as the carrier for polysaccharide of Larimichthys crocea swimming bladder.

Lian-Hong Chen, Jia-Le Song, Yu Qian, Xin Zhao, Hua-Yi Suo, Jian Li

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Foods (Basel, Switzerland) · 2026
    Article
  3. In Vivo Biocompatibility ofJournal of functional biomaterials · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Prophylactic Effect ofEvidence-based complementary and alternative medicine : eCAM · 2020
    Article
  10. Preventative effects of fermentedExperimental and therapeutic medicine · 2017
    Article
  11. Article
  12. Preventive effects ofOncology letters · 2014
    Article
  13. Preventive Effect of Polysaccharide of Larimichthys crocea Swim Bladder on Reserpine Induced Gastric Ulcer in ICR Mice.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2014
    Article
  14. Article
  15. Therapeutic Effect ofPharmacognosy magazine
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Lian-Hong ChenCollege of Life Science and Technology, Southwest University for Nationalities, Chengdu 610041, China. cdchenlianhong@gmail.com.
Jia-Le SongCollege of Life Science and Technology, Southwest University for Nationalities, Chengdu 610041, China. biopaul@pusan.ac.kr.
Yu QianCollege of Life Science and Technology, Southwest University for Nationalities, Chengdu 610041, China. foodmed@live.com.
Xin ZhaoCollege of Life Science and Technology, Southwest University for Nationalities, Chengdu 610041, China. zhaoxin@pnu.edu.
Hua-Yi SuoCollege of Life Science and Technology, Southwest University for Nationalities, Chengdu 610041, China. birget@swu.edu.cn.
Jian LiCollege of Life Science and Technology, Southwest University for Nationalities, Chengdu 610041, China. lijian@swun.cn.
Southwest Minzu University · CNChongqing University of Education · CNPusan National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The preventive effect of polysaccharide of Larimichthys crocea swimming bladder (PLCSB) and the increase of this effect by use of resistant starch (RS3) as the carrier for PLCSB on azoxymethane (AOM) and dextran sulfate sodium (DSS)-inducing colon carcinogenesis in C57BL/6 mice has been studied. RS3 microspheres carrying PLCSB (RS3 + PLCSB) were produced and evaluated as a potentially improved colon carcinogenesis therapy for this study. The body weight, colon length, and colon weight of mice were determined, and colonic tissues were histologically observed. The serum levels of proinflammatory cytokines and the inflammation and apoptosis-related genes in colonic tissue were also tested. The PLCSB or RS3 + PLCSB significantly suppressed AOM and DSS-induced body weight loss, colon length shortening and decreased the colon weight to length ratio. PLCSB or RS3 + PLCSB reduced the levels of the serum pro-inflammatory cytokines IL-6, IL-12, TNF-α, and IFN-γ to a greater extent compared with the control mice, and the levels of RS3 + PLCSB were more close to the normal mice than PLCSB treated mice. Histopathological examination of sections of colon tissues showed that the RS3 + PLCSB group recovered well from colon carcinogenesis; however, the tissue sections of the stachyose + starch could reduce the necrosis degree. PLCSB significantly induced apoptosis in tissues of mice (p < 0.05) by up-regulating Bax, caspase-3, and caspase-9, and down-regulating Bcl-2. The expression of genes associated with inflammation-related NF-κB, iNOS, and COX-2 genes, was significantly down-regulated, and IκB-α was up-regulated (p < 0.05). These results suggest that PLCSB is a potent preventive against in vivo colon carcinogenesis and that PLCSB with an RS3 carrier could increase the preventative effect in mice.

Indexed as

AnimalsApoptosis Regulatory ProteinsAzoxymethaneBody WeightColonic NeoplasmsCytokinesDextran SulfateDown-RegulationGene ExpressionInflammation MediatorsMaleMiceMice, Inbred C57BLPerciformesPolysaccharidesStarchApoptosis Regulatory ProteinsAzoxymethaneCytokinesDextran SulfateInflammation MediatorsPolysaccharidesStarch

Identifiers

PMID24413751
PMCPMC3907840
OpenAlexW2069904167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.